|
[1]KRAWITT EL.Autoimmune hepatitis[J].N Engl J Med, 2006, 354 (1) :54-66.
|
|
[2]SUI M, WU R, HU X.et al.Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient population[J].J Viral Hepat, 2014, 21 (12) :925-929.
|
|
[3]CHEN J, ESLICK GD, WELTMAN M.Systematic review with metaanalysis:Clinical manifestations and management of autoimmune hepatitis in the elderly[J].Aliment Pharmacol Ther, 2014, 39 (2) :117-124.
|
|
[4]MA YX, YAN HP, ZHANG HP, et al.Detection and Significance of Antibodies to nucleolus in patients with various liver diseases[J].Chin J Lab Diag, 2015, 19 (4) :567-569. (in Chinese) 马胤雪, 闫惠平, 张海萍, 等.抗核仁抗体在肝病患者中的检测及其意义[J].中国实验诊断学, 2015, 19 (4) :567-569.
|
|
[5]YANG F, WANG Q, BIAN Z, et al.Autoimmune hepatitis:East meets west[J].J Gastorenterol Heptol, 2015, 30 (8) :1230-1236.
|
|
[6]RIGOPOULOU EI, ZACHOU K, GATSELIS N, et al.Autoimmune hepatitis in patients with chronic HBV and HCV infections:Patterns of cllnicalcharacterstics, diseaseprogression and outcome[J].Ann Hepatol, 2013, 13 (1) :127-135.
|
|
[7]DALEKOS GN, ZACHOU K, LIASKOS C, et al.Autoantibodies and defined target autoantigens in autoimmune hepatitis:Anoverview[J].Eur J Intern Med, 2002, 13 (5) :293-303.
|
|
[8]CZAJA AJ.Perfornmance parameters of the conventional serological markers for autoimmune hepatitis[J].Dig Dis Sci, 2001, 56 (2) :545-554.
|
|
[9]KERKAR N, CHOUDHURI K, MA Y, et al.Cytochrome P4502D6:Anew immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positiveliver disease[J].JImmunol, 2003, 170 (3) :1481-1489.
|
|
[10]MIAO Q, BIAN Z, TANG R, et al.Emperipolesis mediated by CD8 T cells is a characteristic histopathologicferture of autoimmune hepatitis[J].Clin Rev Allergy Immunol, 2015, 48 (2-3) :226-235.
|
|
[11]WANG ZY, WANG QX, MA X.Diagnosis and treatment of autoimmune hepatitis complicated with viral hepatitis[J].Chin Hepatol, 2015, 20 (12) :1003-1006. (in Chinese) 王昭月, 王绮夏, 马雄.自身免疫性肝病合并病毒性肝炎的诊断及治疗[J].肝脏, 2015, 20 (12) :1003-1006.
|
|
[12]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
|
|
[13]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and mangement of autoimmune hepatitis (2015) [J].J Clin Hepatol, 2016, 32 (1) :9-22. (in Chinese) .中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2016, 32 (1) :9-22.
|
|
[14]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for hepatitis C:A 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1961-1979. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.丙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1961-1979.
|
|
[15]Expert Committee on Clinical Application of Glycyr-rhizin Preparation in the Treatment of Liver Diseases.Expert consensus on clinical application of glycyrrhizin preparation in the treatment of liver diseases[J].J Clin Hepatol, 2016, 32 (5) :844-852. (in Chinese) 甘草酸制剂肝病临床应用专家委员会.甘草酸制剂肝病临床应用专家共识[J].临床肝胆病杂志, 2016, 32 (5) :844-852.
|
DownLoad: